Sona Nanotech Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNANF research report →
Companywww.sonanano.com
Sona Nanotech Inc. , nanotechnology life sciences company, manufactures and sells gold nanorod products for diagnostic tests. The company also provides Nanotech COVID-19 Lateral Flow Assay, an immunochromatographic assay for the detection of the spike protein antigen from SARS-CoV-2 in saliva specimens from individuals, who are suspected of COVID-19; Gemini gold nanorods; Omni gold nanorods for medical applications; and contract services.
- CEO
- David Andrew Regan
- IPO
- 2006
- Employees
- 8
- HQ
- Halifax, NS, CA
Price Chart
Valuation
- Market Cap
- $27.68M
- P/E
- -12.77
- P/S
- 0.00
- P/B
- -235.43
- EV/EBITDA
- -15.66
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -1043.04%
- ROIC
- -1878.24%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-3,249,908 · -20.19%
- EPS
- $-0.03 · -7.43%
- Op Income
- $-3,441,821
- FCF YoY
- -0.05%
Performance & Tape
- 52W High
- $0.65
- 52W Low
- $0.20
- 50D MA
- $0.24
- 200D MA
- $0.35
- Beta
- 0.79
- Avg Volume
- 5.14K
Get TickerSpark's AI analysis on SNANF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SNANF Coverage
We haven't published any research on SNANF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SNANF Report →